• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Microbes Infect . High Anal Swab Viral Load Predisposes Adverse Clinical Outcomes in Severe COVID-19 Patients

tetano

Editor, Senior Moderator
Emerg Microbes Infect


. 2020 Dec 1;1-26.
doi: 10.1080/22221751.2020.1858700. Online ahead of print.
High Anal Swab Viral Load Predisposes Adverse Clinical Outcomes in Severe COVID-19 Patients


Haibo Li[SUP] 1 2 [/SUP], Lili Ren[SUP] 3 4 [/SUP], Lulu Zhang[SUP] 3 [/SUP], Yeming Wang[SUP] 1 5 [/SUP], Li Guo[SUP] 3 4 [/SUP], Conghui Wang[SUP] 3 [/SUP], Yan Xiao[SUP] 3 4 [/SUP], Ying Wang[SUP] 3 [/SUP], Jian Rao[SUP] 3 [/SUP], Xinming Wang[SUP] 3 [/SUP], Ying Liu[SUP] 6 [/SUP], Chaolin Huang[SUP] 6 [/SUP], Xiaoying Gu[SUP] 7 [/SUP], Guohui Fan[SUP] 7 [/SUP], Hui Li[SUP] 1 2 [/SUP], Binghuai Lu[SUP] 1 2 [/SUP], Bin Cao[SUP] 1 2 5 8 [/SUP], Jianwei Wang[SUP] 3 4 [/SUP]



Affiliations

Abstract

The pandemic coronavirus disease 2019 (COVID-19) is characterized by systemic infection and multiorgan dysfunction. The association between the kinetics of viral load and clinical outcome in severe COVID-19 patients has not been well established. A retrospective study was performed on clinical specimens from 188 hospitalized severe COVID-19 patients involved in the LOTUS China trial. A total of 578 paired throat swab (TS) and anal swab (AS) samples were collected. Viral load was measured by using quantitative real-time PCR. Viral RNA was detected in 193 (33.4%) TS and 121 (20.9%) AS samples. A higher viral RNA load was found in TS than in AS, with means of 1.0?10[SUP]6[/SUP] and 2.3?10[SUP]5[/SUP] copies/ml, respectively. The median number of days from symptom onset to positive virus detection in AS samples was significantly lower in non-survivors than in survivors (14 days vs 19 days, P=0.007). The virus positive rate in AS (P=0.006) and the viral load in AS (P=0.006) were significantly higher in non-survivors than in survivors at week 2 post symptom onset. A high initial viral load in AS was associated with death (OR 1.368, 95% CI 1.076-1.741, P=0.011), admission to the intensive care unit (OR 1.237, 95% CI 1.001-1.528, P=0.049) and need for invasive mechanical ventilation (OR 1.340, 95% CI 1.076-1.669, P=0.009) in COVID-19 patients. A high viral load and early positive virus detection in AS predispose adverse outcomes of COVID-19. Viral replication in extrapulmonary sites should be monitored intensively during antiviral therapy.

Keywords: COVID-19; SARS-CoV-2; anal swabs; clinical outcome; viral load.
 
Back
Top Bottom